CJC-1295/Ipamorelin is two peptides on two different pathways acting on the same pituitary cell at the same time
Data source, study protocol and patient selection Data for this investigation were accessed through the TriNetX Analytics platform, a global collaborative health research network widely used in numerous prominent epidemiological studies (Supplementary appendix) 43,44,45
While obesity itself increases blood clot risk two to three-fold, the weight loss injections do not add to that risk
You might be a candidate if: You have a BMI of 30 or higher (classified as obesity) You have a BMI of 27 or higher with at least one weight-related condition such as: High blood pressure High cholesterol Sleep apnea Fatty liver disease Polycystic ovary syndrome (PCOS) Joint problems related to excess weight Clinical trials have shown that Mounjaro can help people lose an average of 15-20% of their body weight over about a year, which is significantly more than most other anti-obesity medications
novo nordisk Wegovy semaglutide injection 2.4mg Wadden TA, Bailey TS, Billings LK, Davies M, Frias JP, Koroleva A, Lingvay I, ONeil PM, Rubino DM, Skovgaard D, Wallenstein SOR, Garvey WT
Significant weight loss achieved with these agents may indirectly affect menstrual regularity, but the medicines themselves do not have an established direct effect on the menstrual cycle per their UK SmPCs